Return to Article Details
UNDERPRESCRIPTION OF SGLT2i IN TYPE 2 DIABETES PATIENTS WITH CARDIORENAL DISEASE IN A PUBLICLY FUNDED TERTIARY CENTER IN MALAYSIA
Download
Download PDF